# Bermuda Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Bermuda HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Bermuda (BMU)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $13.8M
- Products: 23
- Buyer markets: 19
- Average CAGR: +11.1%
- Global sector size: $306.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $224.5B | $8.4M | $84.0B | +9.8% | 13 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $24.0B | $14.6K | $9.1B | -5.0% | 10 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $15.1B | $144.3K | $7.6B | -4.2% | 11 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $9.0B | $89.5 | $6.0B | -34.5% | 2 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.3B | $3.0M | $3.5B | +96.3% | 1 | +0.2% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $9.4B | $1.9M | $3.4B | +17.2% | 4 | +0.1% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $4.3B | $16.8 | $1.5B | +369.8% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.7B | $187.4K | $1.2B | +62.0% | 1 | +0.5% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.1B | $4.6 | $719.0M | -13.6% | 1 | +0.0% |
| HS 370500 - Photographic plates and film: exposed and developed, other than cinematographic film | $452.8M | $75.2 | $675.1M | -3.0% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $48.0 | $640.9M | -15.1% | 1 | +0.0% |
| HS 320910 - Paints and varnishes: based on acrylic or vinyl polymers, dispersed or dissolved in an aqueous medium | $513.1M | $2.8 | $614.3M | -12.0% | 1 | +0.0% |
| HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $492.9 | $579.1M | +60.5% | 1 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $529.8M | $238.2 | $535.0M | -44.6% | 1 | +0.0% |
| HS 300590 - Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | $926.9M | $280.3 | $409.9M | +9.8% | 1 | +0.0% |
| HS 330590 - Hair preparations: n.e.s. in heading no. 3305 | $467.9M | $47.0 | $357.9M | +11.6% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $430.7M | $48.6 | $313.7M | +7.0% | 1 | +0.0% |
| HS 340119 - Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, not for toilet use | $403.3M | $7.7 | $313.4M | -2.3% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $517.9M | $0.6 | $247.7M | -2.6% | 1 | +0.0% |
| HS 330410 - Cosmetic and toilet preparations: lip make-up | $852.7M | $780.5 | $220.1M | +78.6% | 1 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $590.6M | $226.0 | $217.7M | -7.1% | 1 | +0.0% |
| HS 340111 - Soap and organic surface-active products: in the form of bars, cakes, moulded shapes, and paper, wadding, felt and nonwovens, impregnated, coated or covered with soap or detergent, for toilet use (including medicated products) | $237.0M | $98.3 | $205.8M | +15.6% | 1 | +0.0% |
| HS 321410 - Mastics: painters' fillings | $523.9M | $8.9K | $195.2M | +5.5% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $36.5B calculated opportunity across 13 products.
- Switzerland, Liechtenstein (CHE): $28.0B calculated opportunity across 2 products.
- Canada (CAN): $10.6B calculated opportunity across 12 products.
- China (CHN): $7.9B calculated opportunity across 2 products.
- Belgium (BEL): $7.3B calculated opportunity across 2 products.
- United Kingdom (GBR): $6.1B calculated opportunity across 4 products.
- Netherlands (NLD): $5.9B calculated opportunity across 3 products.
- Italy (ITA): $5.4B calculated opportunity across 2 products.
- Ireland (IRL): $4.2B calculated opportunity across 3 products.
- France (FRA): $3.7B calculated opportunity across 3 products.
- Singapore (SGP): $2.0B calculated opportunity across 2 products.
- South Africa (ZAF): $1.2B calculated opportunity across 2 products.

## Growth stars

- HS 300215: +369.8% average CAGR, $1.5B calculated opportunity.
- HS 300439: +96.3% average CAGR, $3.5B calculated opportunity.
- HS 330410: +78.6% average CAGR, $220.1M calculated opportunity.
- HS 300220: +62.0% average CAGR, $1.2B calculated opportunity.
- HS 330749: +60.5% average CAGR, $579.1M calculated opportunity.
- HS 382200: +17.2% average CAGR, $3.4B calculated opportunity.
- HS 340111: +15.6% average CAGR, $205.8M calculated opportunity.
- HS 330590: +11.6% average CAGR, $357.9M calculated opportunity.
- HS 300590: +9.8% average CAGR, $409.9M calculated opportunity.
- HS 300490: +9.8% average CAGR, $84.0B calculated opportunity.

## Diversification opportunities

- HS 300490: 13 buyer markets, $84.0B calculated opportunity.
- HS 330300: 11 buyer markets, $7.6B calculated opportunity.
- HS 330499: 10 buyer markets, $9.1B calculated opportunity.
- HS 382200: 4 buyer markets, $3.4B calculated opportunity.
- HS 382499: 2 buyer markets, $6.0B calculated opportunity.
- HS 300439: 1 buyer markets, $3.5B calculated opportunity.
- HS 300215: 1 buyer markets, $1.5B calculated opportunity.
- HS 300220: 1 buyer markets, $1.2B calculated opportunity.
- HS 340220: 1 buyer markets, $719.0M calculated opportunity.
- HS 370500: 1 buyer markets, $675.1M calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.